GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) » Definitions » Owner Earnings per Share (TTM)

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Owner Earnings per Share (TTM) : 0.00 (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Cryofocus Medtech (Shanghai) Co Owner Earnings per Share (TTM)?

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Cryofocus Medtech (Shanghai) Co's Owner Earnings per Share (TTM) ended in Dec. 2024 was HK$0.00. It's Price-to-Owner-Earnings ratio for today is 0.


The historical rank and industry rank for Cryofocus Medtech (Shanghai) Co's Owner Earnings per Share (TTM) or its related term are showing as below:



HKSE:06922's Price-to-Owner-Earnings is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 29.39
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

Cryofocus Medtech (Shanghai) Co's Earnings per Share (Diluted) for the six months ended in Jun. 2024 was HK$-0.24. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-0.47. It's PE Ratio (TTM) ratio for today is At Loss.

Cryofocus Medtech (Shanghai) Co's EPS without NRI for the six months ended in Jun. 2024 was HK$-0.24. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-0.47. It's PE Ratio without NRI ratio for today is At Loss.


Cryofocus Medtech (Shanghai) Co Owner Earnings per Share (TTM) Historical Data

The historical data trend for Cryofocus Medtech (Shanghai) Co's Owner Earnings per Share (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryofocus Medtech (Shanghai) Co Owner Earnings per Share (TTM) Chart

Cryofocus Medtech (Shanghai) Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Owner Earnings per Share (TTM)
- - - - -

Cryofocus Medtech (Shanghai) Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Owner Earnings per Share (TTM) Get a 7-Day Free Trial - - - - -

Competitive Comparison of Cryofocus Medtech (Shanghai) Co's Owner Earnings per Share (TTM)

For the Medical Devices subindustry, Cryofocus Medtech (Shanghai) Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cryofocus Medtech (Shanghai) Co's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cryofocus Medtech (Shanghai) Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Cryofocus Medtech (Shanghai) Co's Price-to-Owner-Earnings falls into.


;
;

Cryofocus Medtech (Shanghai) Co Owner Earnings per Share (TTM) Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

To make it simple, then you will have:

Owner Earnings per Share (TTM) = (Net Income + Depreciation, Depletion and Amortization + Change In Deferred Tax - 5Y Average of Maintenance Capital Expenditure + Change In Working Capital) / Shares Outstanding (Diluted Average)

Cryofocus Medtech (Shanghai) Co's Owner Earnings per Share (TTM) Calculation:

Last Year Average of Last 5 Years
Net Income -111.43
Depreciation, Depletion and Amortization 0.00
Change In Deferred Tax 0.00
5Y Average of Maintenance Capital Expenditure 10.36
Change In Working Capital 0.00
Shares Outstanding (Diluted Average) 239.11

1. Start with "Net Income" from income statement. Cryofocus Medtech (Shanghai) Co's Net Income for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-111.43 Mil.

2. "Depreciation, Depletion and Amortization" is from cashflow statement. Cryofocus Medtech (Shanghai) Co's Depreciation, Depletion and Amortization for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.00 Mil. This needs to be added back because company does not actually need to pay cash for it. It is a non-cash item.

3. Other non-cash charges usually include "Stock Based Compensation" and "Change In Deferred Tax":
However, to be conservative, GuruFocus will not add Stock Based Compensation back to net income. Cryofocus Medtech (Shanghai) Co's Change In Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.00 Mil.

4. Average maintenance capital expenditure over a business/industry cycle: 5-Year Average Maintenance Capital Expenditure = HK$10.36 Mil

It is usually best to take a long-term average of maintenance capital expenditure. Ideally this would be as long as 10 years and include at least one economic downturn. However, since many companies do not have as long as 10-year history, here GuruFocus uses the latest 5 years data to do the calculation. To smooth out unusual years but reflect recent developments, we take an average of the 5 year maintenance capital expenditure.

The following shows how to get maintenance capital expenditure.

First, calculate the revenue change regarding to the previous year. If the revenue decreased from the previous year, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
Second, if the revenue increased from the previous year, then calculate the percentage of Net PPE as of corresponding Revenue.
Growth Capital Expenditure = Percentage of Property, Plant and Equipment as of corresponding Revenue * Revenue Increase
Third, calculate Capital Expenditure (positive) - Growth Capital Expenditure.
If [Capital Expenditure (positive) - Growth Capital Expenditure] was negative, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
If [Capital Expenditure (positive) - Growth Capital Expenditure] was positive, then the Maintenance Capital Expenditure = Capital Expenditure (positive) - Growth Capital Expenditure.
Fourth, get the average of the 5 years maintenance capital expenditure.

Cryofocus Medtech (Shanghai) Co's 5-Year Average Maintenance Capital Expenditure = HK$10.36 Mil

5. "Change In Working Capital" is from cashflow statement. Cryofocus Medtech (Shanghai) Co's Change In Working Capital for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.00 Mil.
Note: GuruFocus' Change in Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And sometimes it includes non-current parts of assets and liabilities.

6. Cryofocus Medtech (Shanghai) Co's Shares Outstanding (Diluted Average) for the months ended in Dec. 2024 was 239.110 Mil.

Cryofocus Medtech (Shanghai) Co's Onwer Earnings Per Share for Dec. 2024 is calculated as:

Owner Earnings per Share (TTM)
=( Net Income+Depreciation, Depletion and Amortization+Change In Deferred Tax
=( -111.428 +0+0
-5Y Avg of Maintenance CAPEX+Change In Working Capital )/Shares Outstanding (Diluted Average)
-10.36225+0)/239.110
=0.00

Price-to-Owner-Earnings=Current Price/Owner Earnings per Share (TTM)
=5.49/0.00
=0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.

Note: GuruFocus' Change In Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.


Cryofocus Medtech (Shanghai) Co Owner Earnings per Share (TTM) Related Terms

Thank you for viewing the detailed overview of Cryofocus Medtech (Shanghai) Co's Owner Earnings per Share (TTM) provided by GuruFocus.com. Please click on the following links to see related term pages.


Cryofocus Medtech (Shanghai) Co Business Description

Traded in Other Exchanges
N/A
Address
Lane 3399, Kangxin Road, Building 15, Pudong New Area, Shanghai, CHN, 200120
Cryofocus Medtech (Shanghai) Co Ltd is a medical device company engaged in the research and development, manufacture, and sale of cryoablation minimally invasive interventional treatment technology and related medical products. The products offered by the company include; Bladder Cryoablation System, Pulmonary Nodule Localization Needle, and Endoscopic Clip for Anastomosis among others. Geographically, the company's revenue is generated from the sale of medical consumables and devices in the Chinese Mainland.
Executives
Zhuhai Junheng Investment L.p. (limited Partnership) 2101 Beneficial owner
Shang Hai Shi Di Sheng Wu Ke Ji You Xian Gong Si
Lv Shiwen 2103 Interests held jointly with another person
Shenzhen Gao Ling Tiancheng Iii Investment Co., Ltd. 2201 Interest of corporation controlled by you
Ning Bo Lin Feng Sheng Wu Ke Ji You Xian Gong Si
Wu Jianhui 2101 Beneficial owner
Li Hui 2202 Interest of your spouse
Shang Hai Shi Di Shi Ye Fa Zhan You Xian Gong Si
Sun Xiaolu 2201 Interest of corporation controlled by you
Fu Guo Ji Jin Guan Li You Xian Gong Si 2102 Investment manager
Hang Zhou Bi Lin Xing Chuang Xin Tou Zi He Huo Qi Ye You Xian He Huo
Shang Hai Bi Lin Xing Zi Chan Guan Li You Xian Gong Si
Hang Zhou Bi Lin Xing Chuang Xin Tou Zi Guan Li He Huo Qi Ye You Xian He Huo
Sheng Shan Zi Chan Guan Li Shang Hai You Xian Gong Si
Gan Shi Xiong

Cryofocus Medtech (Shanghai) Co Headlines

No Headlines